ExodusPoint Capital Management’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
Other funds holding COLL
EAM
VCM
ExodusPoint Capital Management's COLL Position: Q1 2026 in Review
ExodusPoint Capital Management sold out of Collegium Pharmaceutical (COLL) in Q1 2026, closing a stake of 105,185 shares — an estimated $4.87M sold.
ExodusPoint Capital Management first reported a position in COLL in Q3 2020 and held it in 14 quarters. The position peaked at $5.87M in Q1 2025. 266 funds tracked by Wall St. Rank hold COLL as of Q1 2026.
- ExodusPoint Capital Management reported no remaining Collegium Pharmaceutical position as of Q1 2026 after selling out during the quarter.
- ExodusPoint Capital Management sold 105,185 Collegium Pharmaceutical shares in Q1 2026, an estimated $4.87M.
- ExodusPoint Capital Management first reported a position in Collegium Pharmaceutical in Q3 2020 and held it in 14 quarters.
- ExodusPoint Capital Management's Collegium Pharmaceutical position peaked at $5.87M in Q1 2025.
- 266 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.
Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.